Journal of biochemical and molecular toxicology, vol.35, no.5, 2021 (SCI-Expanded)
Glioma is the most common brain tumor. C6 rat glioblastoma cells provide the
possibility to the scientist to study brain cancer. Concanavalin A (Con A) has a lot of
antitumoral effects, especially over oxidative stress. In the present study, it was
aimed to decide the impacts of various doses of Con A on C6 glioblastoma cells
regarding cytotoxicity, thiol/disulfide homeostasis, apoptosis, and inflammation. We
detected the cytotoxic activity of Con A (from 7.8 to 500 µg/ml) in C6 cells by
utilizing 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyl tetrazolium bromide (MTT) and
determined the toxic concentration of Con A. Once the optimal doses were found,
the thiol–disulfide homeostasis, levels of total antioxidant and oxidant status (TAS
and TOS), malondialdehyde (MDA) and glutathione (GSH), pro‐inflammatory cytokines as tumor necrosis factor‐alpha (TNF‐α) and interleukin‐6 (IL‐6), apoptotic
proteins as cytochrome c (CYCS), and caspase 3 (CASP3) were measured. Apoptotic
and morphological changes in the C6 cells were examined with an inverted microscope and flow cytometry technique. Dose‐dependent Con A triggered oxidative
damage in the C6 cells, affecting the inflammatory pathway, so reducing proliferation with apoptotic proteins and morphological changes. But especially, Con A increased disulfide formation by disrupting the thiol/disulfide balance in C6 cells. This
study revealed that Con A, known as carbohydrate‐binding protein, generated
oxidative damage, inflammation, and apoptosis in a dose‐dependent manner by
modulating thiol/disulfide homeostasis in C6 glioblastoma cells.